Good Steward Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$399K Buy
333
+8
+2% +$8.17K 0.24% 38
2026
Q1
$299K Sell
325
-27
-8% -$27.4K 0.19% 46
2025
Q4
$378K Sell
352
-18
-5% -$17.2K 0.25% 39
2025
Q3
$282K Sell
370
-141
-28% -$105K 0.2% 63
2025
Q2
$398K Sell
511
-69
-12% -$53.6K 0.31% 50
2025
Q1
$479K Buy
+580
New +$483K 0.44% 58

Other funds holding LLY

Good Steward Wealth Advisors's LLY Position: Q2 2026 in Review

Good Steward Wealth Advisors increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $8.17K and bringing the position to 333 shares worth $399K. The position accounts for 0.24% of the portfolio, ranked #38.

Good Steward Wealth Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $479K in Q1 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Good Steward Wealth Advisors held 333 shares of Eli Lilly worth $399K as of Q2 2026.
  • Good Steward Wealth Advisors bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.24% of Good Steward Wealth Advisors's portfolio in Q2 2026, its #38 holding.
  • Good Steward Wealth Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Good Steward Wealth Advisors's Eli Lilly position peaked at $479K in Q1 2025.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Good Steward Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.